Pacific Biosciences of California Inc (NAS:PACB)
$ 1.86 -0.07 (-3.63%) Market Cap: 568.03 Mil Enterprise Value: 1.02 Bil PE Ratio: 0 PB Ratio: 1.17 GF Score: 55/100

Q2 2021 Pacific Biosciences of California Inc Earnings and to Discuss Acquisition of Circulomics Inc Call Transcript

Aug 03, 2021 / 08:30PM GMT
Release Date Price: $30.21 (-3.30%)
Operator

Good afternoon, ladies and gentlemen, and welcome to the Pacific Biosciences of California, Inc. Second Quarter 2021 Earnings Conference Call. (Operator Instructions) As a reminder, this conference call is being recorded. I would like to turn the conference over to your host today, Mr. Todd Friedman, Director of Investor Relations. Sir, you may begin.

Todd Friedman
Pacific Biosciences of California, Inc. - Director of IR

Good afternoon, and welcome to the Pacific Biosciences Second Quarter 2021 Earnings Conference Call. Earlier today, we issued a press release outlining the financial results we will be discussing on today's call, a copy of which is available in the Investors section of our website at www.pacb.com or alternatively as furnished on Form 8-K available on the Securities and Exchange Commission website at www.sec.gov.

With me today are Christian Henry, President and Chief Executive Officer; Susan Kim, Chief Financial

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot